Scaling MedTech: From Product to Market

Welcome to our 5-part series on how to take your MedTech innovation from prototype to market-ready — and reimbursed.

This founder-focused guide walks you through the essential elements of MedTech commercialization in 2025 and beyond, with real-world examples, European focus, and actionable insights.

Explore the full series:

Post 1: The MedTech Go-to-Market Playbook (2025 Edition)

How to structure a scalable GTM strategy — from direct sales to digital hybrid.


Post 2: Market Access in Europe — What Founders Need to Know

Breakdown of DiGA, PECAN, NHS, and other national access pathways in Europe.


Post 3: Cracking Reimbursement — Value-Based Pricing for MedTech Startups

Pricing models, cost-effectiveness, and payer expectations decoded.


Post 4: Commercial Channels That Actually Work in MedTech

Best channels for reaching HCPs and institutions — with examples from digital and device companies.


Post 5: Mistakes to Avoid in MedTech Commercialization (and How to Fix Them)

Learn from others’ failures — and build smarter launch plans.